Replies to post #323910 on Avid Bioservices Inc (CDMO)

[swg_tdr]

bio, that $20B is from Ilumina

"Illumina remains the leader in its industry, and management believes that the genomic testing market could eventually exceed $20 billion in annual sales.” as of recent $200B BULL, even in 10 years IMO

even got this from link off your post (just fact checking you)

;-)

[swg_tdr]

bio, int'l cancer mrkt <<<$200B

therefore exosome cannot be bigger or even close to whole market.

Further, competitors seem to go DNA, all per the links of your pos.

best